Document is current
Any future updates will be listed below
-
Authors
Bustos, Ingrid G.
Serrano-Mayorga, Cristian C.
Guerrero, José L.
Baker, Jennifer M.
Brown, Christopher
Falkowski, Nicole
Ranjan, Piyush
Acosta-Gonzalez, Alejandro
Mendez, Lina M.
Garcia-Cordoba, Acenet
Echeverry-Gutierrez, Adriana
Bojaca, Denis A.
Chisica-Mahecha, Marcela
Guarin-Tequia, Nicol
Romero-Romero, Liliana
Gonzalez-Juarbe, Norberto
Rodriguez, Alejandro
Cala, Mónica P.
Martin-Loeches, Ignacio
Chotirmall, Sanjay H.
Dickson, Robert P.
Reyes, Luis F.
-
Funding
Funding for this research was provided by:
Universidad de La Sabana , Colombia (MED-260-2019, MED-260-2019, MED-260-2019, MED-260-2019)
University of Michigan
- License Information
-
More Information
Article History
Received: 30 April 2025
Accepted: 11 June 2025
First Online: 3 July 2025
Declarations
:
: The study was approved by the Institutional Review Board (IRB) of Clínica Universidad de La Sabana, Colombia (IRB 20190903, MED-468). Written informed consent was obtained from all participants or their legal representatives prior to enrolment.
: All authors have reviewed and approved the final manuscript and consent to its publication.
: S.H.C has served on advisory boards for CSL Behring, Pneumagen Ltd., Sanofi, Zaccha Pte. Ltd., and Boehringer Ingelheim, has served on Data Safety and Monitoring Boards (DSMB) for Inovio Pharmaceuticals Ltd and Imam Abdulrahman Bin Faisal University, and received lecture fees from Astra-Zeneca and Chiesi Farmaceutici, all outside of the submitted work.
